THERAVANCE BIOPHARMA INC
TBPH·G8807B106·US·Common Stock·Healthcare - Biotechnology-Activist
TBPH (THERAVANCE BIOPHARMA INC) is held by 107 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($77.6M), VANGUARD CAPITAL MANAGEMENT LLC ($30.1M), STATE STREET CORP ($22.6M). Net institutional sentiment: Mixed.
107
Holders
(6 Elite)
$361.5M
Total Value
56% (109)
Consensus
61 buying - 48 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Sep 21, 2026 · Insiders Sep 17, 2026 · Activists Aug 14, 2026 · Congress none
InsiderFRFarnum RhondaSell $113KSep 15, 2026
InsiderFRFarnum RhondaSell $57KSep 15, 2026
InsiderFRFarnum RhondaSell $57KSep 15, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 121
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer